2BB score and signals
Dyne Therapeutics, Inc.’s current 2BB score is 53 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 65 | High |
| Momentum | 52 | Stable |
| Financial strength | 11 | Very Weak |
| Quality | 93 | Very Strong |
| Risk | 37 | Low |
Company facts
| Headquarters | Waltham, Massachusetts, United States |
| Founded | 2017 |
| Employees | 289 |
| 52-week range | $11.92 – $27.30 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-01 | — | -0.8933 | — | $0.00 |
| 2026-11-02 | — | -0.9045 | — | $0.00 |
| 2026-07-30 | — | -0.7618 | — | $0.00 |
| 2026-05-11 | -0.73 | -0.7808 | $0.00 | $0.00 |
Related companies
